 - Subjects with no prior malignancy, or subjects with cured malignancies other than SCLC if: a they are alive without disease recurrence for at least 5 years from the date of pathological diagnosis, and b clinical expectation of disease recurrence is 5 as documented in the medical record by the responsible physician, and c they have not received any platinum-based therapy. Subjects with basal cell carcinoma or carcinoma in situ of the cervix may be eligible if adequately treated and clinical expectation of disease recurrence is 5 as documented in the medical record by the responsible physician. 